MetaCap

iBio Statistics

NASDAQ: IBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.8001-0.0009 (-0.11%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

iBio by the numbers

iBio has a market capitalization of $56.4 million based on 70.46M shares outstanding. With trailing EPS of $-0.27, iBio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.0% below its 50-day average and 49.5% below its 200-day average.

Average daily trading volume is 678.91K shares, or about $543,195 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IBIO valuation vs. peer median

IBIO compared with the median of 8 peer companies
MetricIBIOPeer medianDifference
Market cap$56.37M$54.89M+3%
Avg. volume678.91K122.68K+453%

Peer median across 8 companies: KZIA, TENX, AZR, BOLD, RANI, XLO, CTOR, XBIT.

Valuation

Market cap
$56.37M
Price / sales (latest FY)
563.72
EPS (TTM)
$-0.27

Price and trading

Previous close
0.801
Open
0.7955
Day range
0.7626 – 0.8266
52-week range
0.68 – 3.82
52-week change
-23.80%
Beta
—
Volume
3.36M

Dividends and events

Annual dividend
None
Next earnings date
Sep 18, 2025

Additional statistics

Market Cap
56.37M
Forward Pe
-1.54
Eps
-0.27
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.82
Week52 Low
0.68
Avg Volume
678.91K
Shares Outstanding
70.46M
Ma50
0.93
Ma200
1.58
Earnings Date
Sep 18, 2025
Pct From52w High
-79.05%
Pct From52w Low
17.66%

Related